Shionogi & Co., Ltd. (Head Office: Osaka, Japan; Chief Executive Officer: Isao Teshirogi, Ph.D.; hereafter "Shionogi") will present new exploratory analyses from the global Phase 3 SCORPIO-PEP study, ...
Fouad Azzam is a Partner with EQT Life Sciences, bringing extensive experience investing in and supporting fast-growing medical technology and life sciences companies. EINDHOVEN, ...
Ascentage Pharma receives China's Breakthrough Therapy Designation for lisaftoclax plus acalabrutinib in untreated CLL/SLL as ...
Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855), a global, commercial-stage, integrated biopharmaceutical ...
Shanghai, China - October 16, 2026 - MicroPort Scientific Corporation announced that it and its associated companies have reached a cumulative total of 50 products accepted into China's National ...
By Nicholas P. Brown NEW YORK, Oct 20 (Reuters) - For Allison Vecchio, 42, GLP-1 drugs were "a reset button on life," but at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results